Aktiesnakken — Juli 2010
-
en konkurrent fik ikke accept hos FDA
-
for et fedmeprodukt
-
Takker...
-
10% ned
-
interessant observation HRmunk
-
de er jo også ude i en massiv slankning af balancen
-
-
mon ikke at Vivus gør det næste gang
-
lige nu håber jeg da at Neuro kan tage sig sammen og levere ordentlige resultater her til 12 mdrs data
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind